Skip to content
MedsAcross

Medicine

Loteprednol etabonate 0.5% ophthalmic gel

Loteprednol etabonate · Ophthalmic
Available on requestPrescription onlyUS FDAGeneric name

Loteprednol etabonate 0.5% ophthalmic gel is a generic prescription medicine for ophthalmic use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store upright at 15º to 25º C (59º to 77º F).

Key facts

Active ingredient (INN)
Loteprednol etabonate
Brand
Sold under the generic name
Strength
0.5%
Dosage form
Ophthalmic gel
Route
Ophthalmic
Packs
1 bottle
Manufacturers
Armas PharmaceuticalsBausch & Lomb AmericasSentiss Pharmaceuticals
Origin register
US FDA, United States
Storage
Store upright at 15º to 25º C (59º to 77º F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
S01BA14 Loteprednol etabonate
HS code (indicative)
3004.32Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
30 June 2023
Identifiers
RxCUI 1312625DailyMed set ID 091a068f-f9b0-b02b-e063-6294a90a95e6, cc8638ae-0444-4a8b-bcad-fa946f607b5d, 1fb8140b-c5a3-40eb-8429-2e570921917bNDC 72485-630, 82260-508, 70244-036Application ANDA212080, NDA202872

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 bottle, dropper in 1 carton / 5 g in 1 bottle, dropper72485-630-05Armas Pharmaceuticals25 October 2023
1 bottle in 1 carton / 5 g in 1 bottle82260-508-01Bausch & Lomb Americas30 June 2023
1 bottle, dropper in 1 carton / 5 g in 1 bottle, dropper70244-036-01Sentiss Pharmaceuticals17 April 2026

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 9 March 1998Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Loteprednol etabonate 0.5% ophthalmic gel.

Compare 1

Other strengths and forms of Loteprednol etabonate

Clinical summary

Loteprednol etabonate is a corticosteroid indicated for the treatment of steroid-responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe such as allergic conjunctivitis, among other approved uses. MedsAcross supplies Loteprednol etabonate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Loteprednol etabonate

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Loteprednol etabonate 0.5% ophthalmic gel for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.